Aytu Biopharma AYTU
NASDAQ AYTU
$1.79 -0.04 (-2.19%)
At close: Nov 9, 2026 · 4:00 PM EST

Aytu Biopharma (AYTU) EV to EBIT (2024)

Updated

Aytu Biopharma's EV to EBIT was -3.33 in fiscal Q3 2024 (quarter ended Mar 31, 2024).

Analysis

Aytu Biopharma (AYTU) EV to EBIT (2024) Analysis & Trends

On a trailing twelve-month basis, Aytu Biopharma's EV to EBIT was -76.75 through Mar 31, 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 Aytu Biopharma 22.17 Mn -93.50 Mn 10.41 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -3.33
API Access

Aytu Biopharma EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=AYTU&period=max&api_key=YOUR_API_KEY